Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TILs and IL-2 in Malignant Pleural Mesothelioma
NCT02414945Phase 2Completed
- Sponsor
- University Health Network
- Start
- May 2015
- Primary completion
- Oct 2020
- Modality
- Allogeneic CAR-T, Tumor-Infiltrating Lymphocytes (TILs), TCR-Engineered T Cells
- Countries
- 1
01
Overview
A Phase 2 trial of MDA-TIL in malignant pleural mesothelioma (MPM), sponsored by University Health Network. Started May 2015; status: completed.
02
Drugs
MDA-TIL
03
Conditions
malignant pleural mesothelioma (MPM)
Beyond the preview
Go deeper on NCT02414945.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02414945.